[Intrathecal opioid infusion pump for chronic cancer and non-cancer pain]
Rey-Ares L, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A
Record ID 32017000279
Spanish
Authors' recommendations:
Scarce evidence of moderate methodological quality suggests that the use of intrathecal opioids in patients with cancer pain is associated to less toxicity because of the use of lower doses, with pain control similar to that of conventional medical treatment with opioids.
Scarce evidence of low methodological quality suggests that with the use of intrathecal opioids greater pain reduction would be achieved than with medical treatment in patients with non-cancer pain.
Both the clinical practice guidelines and the coverage policies consulted consider this treatment in patients with intractable pain or unacceptable toxicity who have failed with conventional alternatives and who have shown good response to the intrathecal opioid administration trial.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Analgesics, Opioid
- Humans
- Infusion Pumps
- Injections, Spinal
- Pain
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.